BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31047955)

  • 21. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
    Camac ER; Voelker H; Criner GJ;
    Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort.
    Kim EK; Kim MA; Lee JS; Lee SM; Lim S; Park J; Kim JH; Oh YM; Lee SD; Lee SH; Lee JH;
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2997-3008. PubMed ID: 34754185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx.
    Sciurba FC; Dransfield MT; Kim V; Marchetti N; Comellas A; Hogarth DK; Majid A
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38151258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.
    Lee JH; Cho MH; Hersh CP; McDonald ML; Crapo JD; Bakke PS; Gulsvik A; Comellas AP; Wendt CH; Lomas DA; Kim V; Silverman EK;
    Respir Res; 2014 Sep; 15(1):113. PubMed ID: 25241909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations.
    Sundqvist M; Andelid K; Ekberg-Jansson A; Bylund J; Karlsson-Bengtsson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():367-377. PubMed ID: 33642857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between oral health and COPD exacerbations.
    Baldomero AK; Siddiqui M; Lo CY; Petersen A; Pragman AA; Connett JE; Kunisaki KM; Wendt CH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():881-892. PubMed ID: 31114185
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
    Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
    Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease.
    Ferrari R; Tanni SE; Caram LM; Naves CR; Godoy I
    Health Qual Life Outcomes; 2011 Dec; 9():112. PubMed ID: 22152155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study.
    Kim V; Han MK; Vance GB; Make BJ; Newell JD; Hokanson JE; Hersh CP; Stinson D; Silverman EK; Criner GJ;
    Chest; 2011 Sep; 140(3):626-633. PubMed ID: 21474571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
    Parekh TM; Bhatia S; Cherrington A; Kim YI; Lambert A; Iyer A; Regan EA; DeMeo DL; Han M; Dransfield MT
    Respir Med; 2020 Jan; 161():105820. PubMed ID: 31759270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction.
    Kim V; Oros M; Durra H; Kelsen S; Aksoy M; Cornwell WD; Rogers TJ; Criner GJ
    PLoS One; 2015; 10(2):e0116108. PubMed ID: 25646735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.
    Miravitlles M; Ferrer M; Pont A; Zalacain R; Alvarez-Sala JL; Masa F; Verea H; Murio C; Ros F; Vidal R;
    Thorax; 2004 May; 59(5):387-95. PubMed ID: 15115864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.